mike.smith@pharmaphorum.com, Author at

Wearable device concept. Smart watch. Health care technology. Sportstech.

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial

Digital tools driving innovative clinical trials

https://pharmaphorum.com/views-and-analysis/digital-tools-driving-innovative-clinical-trials/

Patients/ Views & Analysis/ Views and analysis

Taking patient engagement efforts beyond box-ticking

mike.smith@pharmaphorum.com Cheryl Davis, patient advocacy, patient engagement, Red Thred Solutions 0 Comment

Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do.

Taking patient engagement efforts beyond box-ticking

https://pharmaphorum.com/views-and-analysis/taking-patient-engagement-efforts-beyond-box-ticking/

Podcast/ Slider in video/ Video/ Views and analysis

How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast

mike.smith@pharmaphorum.com COVID-19, health equity, Janssen, mental health, Mohammed Issa 0 Comment

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, vice

How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast

https://pharmaphorum.com/podcast/how-pharma-can-spur-innovation-and-promote-health-equity-in-mental-health/

Sales and Marketing/ Views & Analysis/ Views and analysis

Do pharmaceutical businesses need to rethink what their graduate schemes offer?

mike.smith@pharmaphorum.com graduate schemes, pharma, Pharmanovia, UK government 0 Comment

As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life

Do pharmaceutical businesses need to rethink what their graduate schemes offer?

https://pharmaphorum.com/views-and-analysis/do-pharmaceutical-businesses-need-to-rethink-what-their-graduate-schemes-offer/

Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Digital investment promises to accelerate the use of wearable sensor data in clinical trials

mike.smith@pharmaphorum.com 0 Comment

In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation

Digital investment promises to accelerate the use of wearable sensor data in clinical trials

https://pharmaphorum.com/digital/digital-investment-promises-to-accelerate-the-use-of-wearable-sensor-data-in-clinical-trials/

Debiopharm-Webinar-Image-1200x675-Text-NEW2

Debates/ Debates & Insight/ Digital/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

The Digital Health Start-up Journey: Series A to scale-up

mike.smith@pharmaphorum.com Debiopharm Innovation Fund, digital health, entrepreneurs, investment fund 0 Comment

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on

The Digital Health Start-up Journey: Series A to scale-up

https://pharmaphorum.com/webinars/the-digital-health-start-up-journey-series-a-to-scale-up/

People communication network concept. Social media.

Sales and Marketing/ Views & Analysis/ Views and analysis

Disrupted medical conferences: 2022 and beyond

mike.smith@pharmaphorum.com COVID-19, digital events, medical conferences 0 Comment

How to make it in the new normal Part 1 of this article discussed the massive disruptions to

Disrupted medical conferences: 2022 and beyond

https://pharmaphorum.com/sales-marketing/disrupted-medical-conferences-part-2/

Headset and customer support equipment at call center ready for actively service

Sales and Marketing/ Views & Analysis/ Views and analysis

Disrupted medical conferences: Lessons learnt

mike.smith@pharmaphorum.com COVID-19, digital events, events, medical conferences 0 Comment

The new normal is already here. Get used to it. The COVID-19 pandemic has radically disrupted traditional medical

Disrupted medical conferences: Lessons learnt

https://pharmaphorum.com/sales-marketing/disrupted-medical-conferences-part-1-the-new-normal-is-already-here-get-used-to-it/

Stock exchange market concept, businesswoman hand trader press digital tablet with graphs analysis candle line on table in office, diagrams on screen.

Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Content metrics help generate compelling communication

mike.smith@pharmaphorum.com content metrics, data, data collection, Veeva 0 Comment

Companies seek efficiency and speed to market during the content creation process, review and approval cycles, and thus

Content metrics help generate compelling communication

https://pharmaphorum.com/sales-marketing/content-metrics-help-generate-compelling-communication/

Trending

About Mike Smith

Posts by Mike Smith:

Digital tools driving innovative clinical trials

Taking patient engagement efforts beyond box-ticking

How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast

Do pharmaceutical businesses need to rethink what their graduate schemes offer?

Digital investment promises to accelerate the use of wearable sensor data in clinical trials

The Digital Health Start-up Journey: Series A to scale-up

Disrupted medical conferences: 2022 and beyond

Disrupted medical conferences: Lessons learnt

Content metrics help generate compelling communication

Trending

About Mike Smith

Posts by Mike Smith:

Login